dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Nabbout, Rima |
dc.contributor.author | Belousova, Elena |
dc.contributor.author | Perkovic Benedik, Mirjana |
dc.contributor.author | Carter, Tom |
dc.contributor.author | Cottin, Vincent |
dc.contributor.author | Curatolo, Paolo |
dc.contributor.author | Macaya Ruíz, Alfons |
dc.date.accessioned | 2022-04-25T13:18:35Z |
dc.date.available | 2022-04-25T13:18:35Z |
dc.date.issued | 2021-09 |
dc.identifier.citation | Nabbout R, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry. Front Neurol. 2021 Sep;12:697467. |
dc.identifier.issn | 1664-2295 |
dc.identifier.uri | https://hdl.handle.net/11351/7400 |
dc.description | TOSCA; Epilèpsia; Registre |
dc.description.sponsorship | The study was funded by Novartis Pharma AG. Novartis has contributed to study design, data analysis and the decision to publish. Novartis authors reviewed the draft for submission. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Neurology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject | Epilèpsia - Diagnòstic |
dc.subject | Esclerosi tuberosa - Complicacions |
dc.subject.mesh | Tuberous Sclerosis |
dc.subject.mesh | /complications |
dc.subject.mesh | Epilepsy |
dc.subject.mesh | Treatment Outcome |
dc.title | Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fneur.2021.697467 |
dc.subject.decs | esclerosis tuberosa |
dc.subject.decs | /complicaciones |
dc.subject.decs | epilepsia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.3389/fneur.2021.697467 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Nabbout R] Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Member of EPICARE Network, Necker Enfants Malades Hospital, Université de Paris, Institut Imagine (Inserm U1163), Paris, France. [Belousova E] Department of Pediatrics, Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia. [Benedik MP] Department of Pediatric Neurology, SPS Paediatric Clinic, Ljubljana, Slovenia. [Carter T] Tuberous Sclerosis Association, Nottingham, United Kingdom. [Cottin V] Department of Respiratory Medicine, Hôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France. [Curatolo P] Department of Neurology, Tor Vergata University Hospital, Rome, Italy. [Macaya A] Servei de Neurologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34566842 |
dc.identifier.wos | 000697609400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |